Proteolysis-concentrating on chimeras (PROTACs) and molecular glue degraders (MGDs) are quite possibly the most maturely designed TPD approaches. Within this assessment, we concentrate on both equally preclinical experiments and clinical trials to offer a comprehensive summary of the security and clinical success of PROTACs and MGDs in hematologic malignancies in https://orlandof197wbf0.wikibriefing.com/user